After the transaction, Baker Felix's stake was reported as 6,782,215 shares of Synageva Biopharma Corp stock.
As noted on January 8, 2013, Baker Felix's purchase was done indirectly through "See Footnotes" over 2 transactions on January 4, 2013. The share price for the transaction was $47.53 according to the regulatory filing detailing the trade.
If we look over the past 12 months, Baker Felix has sold no shares of Synageva Biopharma Corp stock. Over the same time period, Baker Felix has purchased 859,720 shares of Synageva Biopharma Corp, with a total cost of $40,862,492.
Let's take a quick, high-level look at insider trading at Synageva Biopharma Corp over the past 12 months. A total of 1,293,927 shares of Synageva Biopharma Corp stock was sold by insiders, totaling $50,409,044. Over the same time 12 month time period, 4,884,440 shares of Synageva Biopharma Corp, for a total value of $190,976,583 were purchased by company insiders.
To view the complete SEC Filing: Synageva Biopharma Corp Form 4 (Insider Trading) SEC Filing